Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus-Infected U.S. Women

Hepatology

Volumn 63, Issue 3, 2016, Pages 712-720

  Kuniholm, Mark H ^a   Ong, Edgar ^b   Hogema, Boris M ^c   Koppelman, Marco ^c   Anastos, Kathryn ^a,d   Peters, Marion G ^e   Seaberg, Eric C ^f   Chen, Yue ^g   Nelson, Kenrad E ^f   Linnen, Jeffrey M ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b HOLOGIC INC   (United States)

^c SANQUIN RESEARCH   (Netherlands)

^d MONTEFIORE MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NUCLEIC ACID;

ACUTE HEPATITIS; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC HEPATITIS; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS E; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; MAJOR CLINICAL STUDY; MIXED INFECTION; PLASMA; POPULATION; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UNITED STATES; VIREMIA; VIRUS ISOLATION; BLOOD; CHRONIC DISEASE; CLINICAL TRIAL; COMPLICATION; GENETICS; HEPATITIS E VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; VIROLOGY;

ADULT; CHRONIC DISEASE; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HIV INFECTIONS; HUMANS; MALE; PROSPECTIVE STUDIES; VIREMIA;

EID: 84955076923     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28384     Document Type: Article

References (52)

1. Johne R, Dremsek P, Reetz J, Heckel G, Hess M, Ulrich RG. Hepeviridae: an expanding family of vertebrate viruses. Infect Genet Evol 2014;27:212-229.
2. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008;48:494-503.
3. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012;55:988-997.
4. Meng XJ. From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety. Virus Res 2011;161:23-30.
5. Nelson KE. Transmission of hepatitis E virus by transfusion: what is the risk? Transfusion 2014;54:8-10.
6. Tohme RA, Drobeniuc J, Sanchez R, Heseltine G, Alsip B, Kamili S, et al. Acute hepatitis associated with autochthonous hepatitis E virus infection-San Antonio, Texas, 2009. Clin Infect Dis 2011;53:793-796.
7. Lewis HC, Boisson S, Ijaz S, Hewitt K, Ngui SL, Boxall E, et al. Hepatitis E in England and Wales. Emerg Infect Dis 2008;14:165-167.
8. Dong C, Meng J, Dai X, Liang JH, Feagins AR, Meng XJ, et al. Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States. J Clin Microbiol 2011;49:4164-4172.
9. Drobeniuc J, Greene-Montfort T, Le NT, Mixson-Hayden TR, Ganova-Raeva L, Dong C, et al. Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg Infect Dis 2013;19:218-222.
10. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009;200:48-56.
11. Teshale EH, Denniston MM, Drobeniuc J, Kamili S, Teo CG, Holmberg SD. Decline in hepatitis E virus antibody prevalence in the United States from 1988-1994 to 2009-2010. J Infect Dis 2015;211:366-373.
12. Holm DK, Moessner BK, Engle RE, Zaaijer HL, Georgsen J, Purcell RH, et al. Declining prevalence of hepatitis E antibodies among Danish blood donors. Transfusion 2015;55:1662-1667.
13. Mansuy JM, Bendall R, Legrand-Abravanel F, Saune K, Miedouge M, Ellis V, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011;17:2309-2312.
14. Thomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ, et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997;35:1244-1247.
15. Dalton HR, Hunter JG, Bendall R. Autochthonous hepatitis E in developed countries and HEV/HIV coinfection. Semin Liver Dis 2013;33:50-61.
16. Ijaz S, Said B, Boxall E, Smit E, Morgan D, Tedder RS. Indigenous hepatitis E in England and wales from 2003 to 2012: evidence of an emerging novel phylotype of viruses. J Infect Dis 2014;209:1212-1218.
17. Pischke S, Behrendt P, Bock CT, Jilg W, Manns MP, Wedemeyer H. Hepatitis E in Germany-an under-reported infectious disease. Dtsch Arztebl Int 2014;111:577-583.
18. Keane F, Gompels M, Bendall R, Drayton R, Jennings L, Black J, et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med 2012;13:83-88.
19. Krain LJ, Nelson KE, Labrique AB. Host immune status and response to hepatitis E virus infection. Clin Microbiol Rev 2014;27:139-165.
20. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008;20:784-790.
21. Peron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007;14:298-303.
22. Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, et al. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 2005;12:1013-1019.
23. Detels R, Jacobson L, Margolick J, Martinez-Maza O, Munoz A, Phair J, et al. The multicenter AIDS Cohort Study, 1983 to ... Public Health 2012;126:196-198.
24. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43:1317-1325.
25. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526.
26. Sauleda S, Ong E, Bes M, Janssen A, Cory R, Babizki M, et al. Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion 2015;55:972-979.
27. Slot E, Hogema BM, Riezebos-Brilman A, Kok TM, Molier M, Zaaijer HL. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013;18. pii: 20550.
28. Meng XJ, Purcell RH, Halbur PG, Lehman JR, Webb DM, Tsareva TS, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A 1997;94:9860-9865.
29. Smith DB, Ijaz S, Tedder R, Hogema B, Zaaijer H, Izopet J, et al. Variability and pathogenicity of Hepatitis E virus genotype 3 variants. J Gen Virol 2015;96:3255-3264.
30. Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993;14:702-715.
31. French AL, Lin MY, Evans CT, Benning L, Glesby MJ, Young MA, et al. Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women. Clin Infect Dis 2009;49:148-154.
32. Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, et al. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology 2010;51:1514-1522.
33. Seaberg EC, Witt MD, Jacobson LP, Detels R, Rinaldo CR, Margolick JB, et al. Spontaneous clearance of the hepatitis C virus among men who have sex with men. Clin Infect Dis 2015;61:1381-1388.
34. Matthews GV, Seaberg E, Dore GJ, Bowden S, Lewin SR, Sasadeusz J, et al. Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals. AIDS 2009;23:1707-1715.
35. Bradley-Stewart AJ, Jesudason N, Michie K, Winter AJ, Gunson RN. Hepatitis E in Scotland: assessment of HEV infection in two high-risk patient groups with elevated liver enzymes. J Clin Virol 2015;63:36-37.
36. Hassing RJ, van der Eijk AA, Lopes VB, Snijdewind IJ, de Man RA, Pas SD, et al. Hepatitis E prevalence among HIV infected patients with elevated liver enzymes in the Netherlands. J Clin Virol 2014;60:408-410.
37. Madejon A, Vispo E, Bottecchia M, Sanchez-Carrillo M, Garcia-Samaniego J, Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 2009;16:895-896.
38. van Welzen BJ, Verduyn Lunel FM, Meindertsma F, Hoepelman AI, Arends JE. Hepatitis E virus as a causative agent of unexplained liver enzyme elevations in HIV-infected patients. J Acquir Immune Defic Syndr 2012;60:e65-e67.
39. Sherman KE, Terrault N, Barin B, Rouster SD, Shata MT. Hepatitis E infection in HIV-infected liver and kidney transplant candidates. J Viral Hepat 2014;21:e74-e77.
40. Kenfak-Foguena A, Schoni-Affolter F, Burgisser P, Witteck A, Darling KE, Kovari H, et al. Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011;17:1074-1078.
41. Pineda JA, Cifuentes C, Parra M, Merchante N, Perez-Navarro E, Rivero-Juarez A, et al. Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients. AIDS 2014;28:1931-1937.
42. Renou C, Lafeuillade A, Cadranel JF, Pavio N, Pariente A, Allegre T, et al. Hepatitis E virus in HIV-infected patients. AIDS 2010;24:1493-1499.
43. Rivero-Juarez A, Martinez-Duenas L, Martinez-Peinado A, Camacho A, Cifuentes C, Gordon A, et al. Absence of occult hepatitis E virus infection among HIV immunosuppressed patients. J Infect 2015;70:680-683.
44. Crum-Cianflone NF, Curry J, Drobeniuc J, Weintrob A, Landrum M, Ganesan A, et al. Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis 2012;18:502-506.
45. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009;361:1025-1027.
46. Abravanel F, Chapuy-Regaud S, Lhomme S, Miedouge M, Peron JM, Alric L, et al. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol 2013;58:624-628.
47. Pas SD, Streefkerk RH, Pronk M, de Man RA, Beersma MF, Osterhaus AD, et al. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol 2013;58:629-634.
48. Pavri TM, Herbst DA, Reddy KR. Chronic hepatitis E virus infection: challenges in diagnosis and recognition in the United States. J Clin Gastroenterol 2015;49:86-88.
49. Hajji H, Gerolami R, Solas C, Moreau J, Colson P. Chronic hepatitis E resolution in a human immunodeficiency virus (HIV)-infected patient treated with ribavirin. Int J Antimicrob Agents 2013;41:595-597.
50. Jagjit Singh GK, Ijaz S, Rockwood N, Farnworth SP, Devitt E, Atkins M, et al. Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV. J Infect 2013;66:103-106.
51. Kaba M, Richet H, Ravaux I, Moreau J, Poizot-Martin I, Motte A, et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol 2011;83:1704-1716.
52. Neukam K, Barreiro P, Macias J, Avellon A, Cifuentes C, Martin-Carbonero L, et al. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis 2013;57:465-468.